A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)
2012 ◽
Vol 48
(17)
◽
pp. 3198-3204
◽
Keyword(s):
Phase Ii
◽